InvestorsHub Logo
Followers 53
Posts 4267
Boards Moderated 0
Alias Born 03/06/2013

Re: stemcell post# 82943

Wednesday, 04/15/2015 12:50:18 PM

Wednesday, April 15, 2015 12:50:18 PM

Post# of 92702
You can call the float 28b, that # includes Sal's 24b control shares which have never been sold to retail via dilution.

They are being used to generate revenue via accelerated share repurchase. The company shorts and covers/retires the shares at a lower price. I.e. Sell at .0002 & cover/retire at .00015.

If you estimate buyback of 4b using this method, you generate between $120k-$200k (.00003-.00005) without actually diluting shareholder equity.

Pros
Generate revenue without dilution
Reduce AS/OS

Cons
Pushes PPS down/limits upside movement
Requires high volume

I like the approach but we need some breathing room to run. At the end of the day, we have about 4b in the non-Sal float. It's been the same for a long time, let's see if that changes in today's disclosure.